JP2021530438A5 - - Google Patents
Info
- Publication number
- JP2021530438A5 JP2021530438A5 JP2020567123A JP2020567123A JP2021530438A5 JP 2021530438 A5 JP2021530438 A5 JP 2021530438A5 JP 2020567123 A JP2020567123 A JP 2020567123A JP 2020567123 A JP2020567123 A JP 2020567123A JP 2021530438 A5 JP2021530438 A5 JP 2021530438A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pharmaceutical composition
- composition according
- seq
- psoriasis
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862677590P | 2018-05-29 | 2018-05-29 | |
| US62/677,590 | 2018-05-29 | ||
| PCT/US2019/034423 WO2019232070A1 (en) | 2018-05-29 | 2019-05-29 | Compositions and methods for treatment of psoriasis |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021530438A JP2021530438A (ja) | 2021-11-11 |
| JP2021530438A5 true JP2021530438A5 (https=) | 2022-06-06 |
| JPWO2019232070A5 JPWO2019232070A5 (https=) | 2022-06-06 |
| JP7357646B2 JP7357646B2 (ja) | 2023-10-06 |
Family
ID=68697289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567123A Active JP7357646B2 (ja) | 2018-05-29 | 2019-05-29 | 乾癬の治療のための組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12016921B2 (https=) |
| EP (1) | EP3801590A4 (https=) |
| JP (1) | JP7357646B2 (https=) |
| KR (1) | KR102940600B1 (https=) |
| CN (1) | CN112689512B (https=) |
| AU (1) | AU2019279883B2 (https=) |
| CA (1) | CA3101767A1 (https=) |
| IL (1) | IL278978B2 (https=) |
| WO (1) | WO2019232070A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10858422B2 (en) | 2016-05-31 | 2020-12-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
| US11690912B2 (en) * | 2018-05-29 | 2023-07-04 | Abcentra, Llc | Methods for treatment of rheumatoid arthritis and accelerated atherosclerosis with an anti-Apo B100 antibody |
| EP4058042A4 (en) * | 2019-11-12 | 2023-12-27 | Abcentra, LLC | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER |
| WO2024194686A2 (en) | 2023-03-17 | 2024-09-26 | Oxitope Pharma B.V. | Anti-phosphocholine antibodies and methods of use thereof |
| WO2025151468A1 (en) * | 2024-01-08 | 2025-07-17 | Abcentra, Llc | Methods of identifying a subject for treatment with antibodies against oxidized low density lipoprotein using pericoronary fat attenuation index |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0103754L (sv) | 2001-04-05 | 2002-10-06 | Forskarpatent I Syd Ab | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
| WO2008104194A1 (en) | 2007-02-28 | 2008-09-04 | Bioinvent International Ab | Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques |
| US8557767B2 (en) * | 2007-08-28 | 2013-10-15 | Uab Research Foundation | Synthetic apolipoprotein E mimicking polypeptides and methods of use |
| UA100255C2 (uk) * | 2007-12-28 | 2012-12-10 | Біоінвент Інтернешенл Аб | Фармацевтична композиція |
| EP2274333A4 (en) * | 2008-03-18 | 2011-06-15 | Abbott Lab | PROCESS FOR TREATING PSORIASIS |
| KR20120111724A (ko) | 2009-08-28 | 2012-10-10 | 제넨테크, 인크. | 항-산화된 ｌｄｌ 항체를 이용한 치료 방법 |
| MX2013003920A (es) * | 2010-10-06 | 2013-06-03 | Abbvie Inc | Metodos para el tratamiento de la psoriasis. |
| WO2016024254A1 (en) | 2014-08-15 | 2016-02-18 | Fundació Hospital Universitari Vall D’Hebron-Institut De Recerca | Therapy selection for psoriasis and psoriatic arthritis |
| US11690912B2 (en) | 2018-05-29 | 2023-07-04 | Abcentra, Llc | Methods for treatment of rheumatoid arthritis and accelerated atherosclerosis with an anti-Apo B100 antibody |
-
2019
- 2019-05-29 US US17/058,537 patent/US12016921B2/en active Active
- 2019-05-29 WO PCT/US2019/034423 patent/WO2019232070A1/en not_active Ceased
- 2019-05-29 JP JP2020567123A patent/JP7357646B2/ja active Active
- 2019-05-29 AU AU2019279883A patent/AU2019279883B2/en active Active
- 2019-05-29 CA CA3101767A patent/CA3101767A1/en active Pending
- 2019-05-29 EP EP19811281.5A patent/EP3801590A4/en active Pending
- 2019-05-29 KR KR1020207037596A patent/KR102940600B1/ko active Active
- 2019-05-29 IL IL278978A patent/IL278978B2/en unknown
- 2019-05-29 CN CN201980050534.6A patent/CN112689512B/zh active Active
-
2024
- 2024-06-21 US US18/750,581 patent/US20250161440A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530438A5 (https=) | ||
| US20240417455A1 (en) | Treatment for rheumatoid arthritis | |
| AU2018200915B2 (en) | Prevention of Adverse Effects Caused by CD3 Specific Binding Domains | |
| JP6554155B2 (ja) | Ｉｌ−１７アンタゴニストを使用して汎発性膿疱性乾癬（ｇｐｐ）を処置する方法 | |
| EP2694107B1 (en) | Treatment for dermatological pathologies | |
| RU2016136364A (ru) | Способы лечения или предупреждения астмы посредством введения антагониста il-4r | |
| JP2025102888A (ja) | Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法 | |
| RU2019111921A (ru) | Способы лечения тяжелого атопического дерматита путем введения ингибитора il-4r | |
| JP2024016237A5 (https=) | ||
| JP2021529766A5 (https=) | ||
| CN109806393B (zh) | 抗pd-1抗体、培美曲塞和铂类药物联合治疗非小细胞肺癌的用途 | |
| JPWO2019232070A5 (https=) | ||
| JP2020521798A5 (https=) | ||
| JPWO2021195530A5 (https=) | ||
| TW202206457A (zh) | 用於治療呼吸疾病之泛elr+ cxc趨化因子抗體 | |
| JPWO2020010024A5 (https=) | ||
| JPWO2022235758A5 (https=) | ||
| Mittal et al. | Monica S. Tandon, Ankit Sharma | |
| CA2884124C (en) | Treatment for rheumatoid arthritis | |
| RU2024105814A (ru) | Лечение атопического дерматита | |
| JPWO2022075476A5 (https=) | ||
| JPWO2023130010A5 (https=) | ||
| JPWO2022197703A5 (https=) | ||
| TH2101002581A (th) | วิธีการทรีตโรคตาโปนจากไทรอยด์โดยใช้แอนติบอดีชนิด anti-fcrn | |
| JPWO2023056355A5 (https=) |